$5.94
0.59[11.03%]
At close: Apr 12
$5.94
0[0.00%]
After Hours: 5:47PM EDT
Aprea Therapeutics
(NASDAQ:APRE)Aprea Therapeutics Stock (NASDAQ:APRE), Insider Trading Activity
Aprea Therapeutics: Insider buying and selling updated today.
Shares Outstanding
5.430M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | John Hamill | SRVP/CFO/PRIN FIN & ACCT OFCR | 1.01K | $7.29 | $7.36K | BUY | 6.97% | 15.503K | Mar 13 | View |
| Mar 14, 2024 | Bernd Seizinger | DIRECTOR | 6.86K | $7.29 | $50.01K | BUY | 25.57% | 33.685K | Mar 13 | View |
| Mar 14, 2024 | JOHN HENNEMAN III | DIRECTOR | 6.86K | $7.29 | $50.01K | BUY | 536.36% | 8.139K | Mar 13 | View |
| Mar 14, 2024 | Oren Gilad | PRESIDENT, CEO | 2K | $7.29 | $14.58K | BUY | 0.62% | 324.77K | Mar 13 | View |
| Jun 08, 2023 | Bernd Seizinger | DIRECTOR | 10.097K | $3.66 | $36.96K | BUY | 62.22% | 26.325K | Jun 06 - Jun 07 | View |
| May 19, 2022 | Bernd Seizinger | DIRECTOR | 50K | $0.71 | $35.50K | BUY | 18.62% | 318.58K | May 18 | View |
| May 19, 2022 | CHRISTIAN SCHADE | CHAIRMAN & CEO | 37.5K | $0.64 | $24.12K | BUY | 14.42% | 297.616K | May 18 | View |
| Mar 01, 2022 | Eyal Attar | SVP, CHIEF MEDICAL OFFICER | -36K | $1.73 | -$62.28K | SELL | -43.29% | 47.159K | Feb 28 | View |
| Dec 03, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0 | $2.44 | -$83.60K | SELL-OPTIONS | 0.00% | 17.167K | Dec 01 | View |
| Nov 03, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0 | $2.96 | -$112.20K | SELL-OPTIONS | 0.00% | 17.167K | Nov 01 | View |
| Oct 05, 2021 | Lars Abrahmsen | SVP, CHIEF SCIENTIFIC OFFICER | 0 | $2.90 | -$198.50K | SELL-OPTIONS | 0.00% | 19K | Oct 01 | View |
| Oct 05, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0 | $2.90 | -$109.17K | SELL-OPTIONS | 0.00% | 17.167K | Oct 01 | View |
| Sep 22, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | -5.46K | $2.95 | -$138.57K | SELL | -24.13% | 17.167K | Sep 20 | View |
| Sep 22, 2021 | Lars Abrahmsen | SVP, CHIEF SCIENTIFIC OFFICER | 0 | $2.94 | -$101.25K | SELL-OPTIONS | 0.00% | 19K | Sep 20 | View |
| Sep 20, 2021 | Eyal Attar | SVP, CHIEF MEDICAL OFFICER | -15.968K | $4.68 | -$74.73K | SELL | -16.11% | 83.159K | Sep 16 | View |
| Feb 16, 2021 | Redmile Group LLCJeremy Green | 10% OWNER | -500K | $5.58 | -$2.79M | SELL | -22.04% | 1.768718M | Dec 28 | View |
| Oct 07, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCAM Opportunities I LPAM Opportunities I GP LLCJOHN DIEKMANAndrew SchwabKUSH PARMARSCOTT ROCKLAGE | -175K | $25.30 | -$4.43M | SELL | -44.93% | 214.462K | Oct 05 | View | |
| Jul 07, 2020 | AB Investments KDevAB Development KarolinskaKB Fund CoInvestment KCIF | -241.703K | $34.55 | -$8.35M | SELL | -10.82% | 1.992586M | Jul 07 | View | |
| Jun 18, 2020 | Scott M Rocklage | -120.164K | $33.30 | -$4.00M | SELL | -61.27% | 75.965K | Jun 16 | View | |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.